Recent Updates
Recently added Catalysts
IART Negative Sentiment Score: 25/100

INTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART

Key Takeaway: Integra LifeSciences Holdings Corporation is currently involved in a class action lawsuit due to alleged failures in disclosing material information. Investors who purchased shares between March 11, 2019, and May 22, 2023, must file lead plaintiff applications by November 13, 2023. The lawsuit follows a significant recall of medical device products attributed to manufacturing practice deviations, which resulted in a 20% drop in the company’s share price. Additionally, Integra has lowered its revenue guidance and faces an expected $22 million impairment charge.

Market Sentiment Analysis

CONCERNS & RISKS

  • Integra LifeSciences is facing a class action lawsuit for failing to disclose material information.
  • The company's revenue guidance was lowered by 6% due to product recalls.
  • Integra's share price dropped 20% following the disclosure of the recall and issues with endotoxins.
  • The company is anticipated to incur a $22 million impairment charge due to inventory write-off.

Full Press Release Details

NEW ORLEANS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 13, 2023 to file lead plaintiff applications in a securities class action lawsuit against Integra LifeSciences Holdings Corporation (NasdaqGS: IART), if they purchased the Company’s shares between March 11, 2019 and May 22, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.
Integra investors should visit us at https://claimsfiler.com/cases/nasdaq-iart/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
Integra and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 23, 2023, the Company disclosed that it was recalling all medical device products made at its Boston Facility between March 1, 2018 and May 22, 2023 due to a deviation from good manufacturing practices in testing for bacterial endotoxin and the release of products with higher levels of endotoxins, as well as an extended halt on production. As a result, the Company lowered its 2Q 2023 revenue guidance by 6% and adjusted earnings per diluted share by 26% and disclosed an expected $22 million impairment charge due to the inventory write-off.
On this news, shares of Integra plummeted $10.24 per share, or 20%, from a closing price of $50.72 per share on May 22, 2023, to a closing price of $40.48 per share on May 23, 2023.
The case is Pembroke Pines Firefighters & Police Officers Pension Fund v. Integra LifeSciences Holdings Corporation, No. 23-cv-20321.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.

Tags

Frequently Asked Questions

What deadline do Integra investors have to file claims?

Integra investors must file lead plaintiff applications by November 13, 2023.

What caused the drop in Integra's share price?

The share price dropped after Integra recalled medical devices and lowered revenue guidance.

Where is the lawsuit against Integra being filed?

The lawsuit is pending in the United States District Court for the District of New Jersey.

Who can investors contact for legal assistance?

Investors can call Kahn Swick & Foti, LLC at toll-free 844-367-9658 for assistance.

How can ClaimsFiler help investors?

ClaimsFiler helps investors access information and submit claims for securities class actions.

Last updated: Oct 25, 2023